Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 535-540

  Hayashi, M ^a   Tokuchi, Y ^a   Hashimoto, T ^a   Hayashi, S I ^a   Nishida, K ^a   Ishikawa, Y ^a   Nakagawa, K ^a   Tsuchiya, S ^a   Okumura, S ^a   Tsuchiya, E ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Chromosome 17p13.3; HIC 1 expression; Lung cancer; Prognosis

Indexed keywords

RNA;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME 17P; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPERMETHYLATED IN CANCER 1 GENE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; RNA ANALYSIS; TELOMERE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; ZINC FINGERS;

EID: 0035056396     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
2. Evidence for a gene on 17p13.3 distal to TP53, as a target for allele loss in breast tumors without p53 mutations
3. Allelotype of non-small cell lung carcinoma - Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma
4. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer
5. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung
6. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers
7. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma
8. Allelic loss on chromosome 17 in human ovarian cancer
9. Allelic deletion on chromosome 17p13.3 in early ovarian cancer
10. Identification of two candidate tumor suppressor genes on chromosome 17p13.3
11. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer
12. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history
13. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
14. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
15. The World Health Organization histological typing of lung tumors, ed. 2
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
17. DNA hypermethylation is associated with 17p allelic loss in neural tumors
18. Association between CpG island methylation and microsatellite instability in colorectal cancer
19. HIC1 hypermethylation is a late event in hematopoietic neoplasms
20. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
21. MDM2 gene amplification and expression in non-small-cell lung cancer: Immunohistochemical expression of its protein is a favorable prognostic marker in patients without p53 protein accumulation
22. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung
23. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas